मूलभूत आँकड़े
| LEI | 984500DD95A35E9BD358 |
| CIK | 1742692 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to InMode Ltd.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
| July 30, 2025 |
Exhibit 99.1 InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins YOKNEAM, Israel, July 30, 2025 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights: ● Quarterly GAAP r |
|
| July 30, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark wh |
|
| May 19, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| April 28, 2025 |
Exhibit 99.1 InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares YOKNEAM, Israel, April 28, 2025 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial res |
|
| April 28, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark w |
|
| April 3, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark w |
|
| April 3, 2025 |
Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel April 3, 2025 Dear Shareholder, You are cordially invited to attend the annual general meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Thursday, May 15, 2025, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha’ar Yokneam Industrial |
|
| March 13, 2025 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| March 11, 2025 |
March 11, 2025 Via EDGAR Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| February 6, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by chec |
|
| February 6, 2025 |
Exhibit 99.1 InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program Quarterly GAAP revenues of $97.9 million and full year revenue of $394.8 million Returned $285.4 million of capital to shareholders in full year 2024 Together with new 10% program, represents repurchase of approximately 27% of shares outstanding within 15 |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES |
|
| February 4, 2025 |
CALCULATION OF FILING FEE TABLES InMode Ltd. Table 1: Newly Registered and Carry Forward Securities Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-8 InMode Ltd. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Newly Registered Securities Fees to be Paid Equity Ordinary shares, NIS 0.01 |
|
| February 4, 2025 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 4, 2025 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section §1350, as adopted pursuant to Section § 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Re |
|
| February 4, 2025 |
As filed with the Securities and Exchange Commission on February 4, 2025 As filed with the Securities and Exchange Commission on February 4, 2025 Registration No. |
|
| February 4, 2025 |
Exhibit 99.1 InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program Quarterly GAAP revenues of $97.9 million and full year revenue of $394.8 million Returned $285.4 million of capital to shareholders in full year 2024 Together with new 10% program, represents repurchase of approximately 27% of shares outstanding within 15 |
|
| February 4, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873, 333-236477, 333-252935, 333-262617 and 333-269749) of InMode Ltd. of our report dated February 4, 2025 relating to the financial statements and the effectiveness of internal control over financial reporting, which app |
|
| February 4, 2025 |
InMode Ltd. Insider Trading Compliance Policy Exhibit 11.1 InMode Ltd. Insider Trading Compliance Policy This Insider Trading Compliance Policy (the “Policy”) describes the standards of InMode Ltd. and its subsidiaries (the "Company") on trading, and causing the trading of, the Company's securities while in possession of material non-public information. This Policy is divided into two parts. 1. The first part prohibits trading in certain circ |
|
| February 4, 2025 |
Addendum No. 6 to Unprotected Lease Agreement from February 28, 2018 Made and signed on June 6, 2024 Exhibit 4.13 Addendum No. 6 to Unprotected Lease Agreement from February 28, 2018 Made and signed on June 6, 2024 Between: Shaar Yokneam – Limited Partnership Partnership No.: 550014666 “Ofer Shaar Yokneam” 28 Hakidmah Street, Yokneam (hereinafter: the “Lessor”) Of the first part; And: InMode Ltd. Private Company No.: 514073618 By means of the authorized signatory Mr. Moshe Mizrahi, I.D.: 05182539 |
|
| February 4, 2025 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), certify that: I have reviewed this Annual Report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 4, 2025 |
Exhibit 12.1 Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this Annual Report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fa |
|
| February 4, 2025 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| October 30, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check m |
|
| October 30, 2024 |
Exhibit 99.1 InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) YOKNEAM, Israel, October 30, 2024 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial |
|
| October 11, 2024 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| October 1, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| October 1, 2024 |
Exhibit 99.1 InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy YOKNEAM, Israel, October 1, 2024 - InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departur |
|
| September 23, 2024 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| September 10, 2024 |
InMode Announces Share Repurchase Program of Up to 7.68 Million Shares Exhibit 99.1 InMode Announces Share Repurchase Program of Up to 7.68 Million Shares YOKNEAM, Israel, Sept. 10, 2024 - InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has approved a share repurchase program of up to 7.68 million ordinary shares. "Following the completion of our share buyback program announced earl |
|
| September 10, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check |
|
| August 1, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check ma |
|
| August 1, 2024 |
Exhibit 99.1 InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre- orders not yet delivered) of $102.6M YOKNEAM, Israel, August 1, 2024 - InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial r |
|
| May 2, 2024 |
Exhibit 99.1 InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of $96M; Company Announces Share Repurchase Program of Up to 8.37 Million Shares; and Appoints New Chairman of the Board of Directors YOKNEAM, Israel, May 2, 2024 - InMode Ltd. (Nasdaq: INMD) (“ |
|
| May 2, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| April 4, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 13, 2024 |
INMD / InMode Ltd. / BoomerangFX International SRL - AMENDMENT NO. 2 Passive Investment SC 13G/A 1 d213242sc13ga2.htm AMENDMENT NO. 2 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the app |
|
| February 13, 2024 |
Exhibit 99.1 InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M YOKNEAM, Israel, Feb. 13, 2024- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2023. Fourth |
|
| February 13, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873, 333-236477, 333-252935, 333-262617 and 333-269749) of InMode Ltd. of our report dated February 13, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which ap |
|
| February 13, 2024 |
INMODE LTD. CLAWBACK POLICY Adopted on November 1, 2023 Exhibit 97 INMODE LTD. CLAWBACK POLICY Adopted on November 1, 2023 The following clawback policy (the “Policy”) of InMode Ltd., an Israeli limited liability company (the “Company”), requires the recovery of erroneously awarded compensation in order to satisfy the requirements of the Nasdaq Stock Market LLC (“Nasdaq”) Listing Rule 5608 (the “Listing Standards”) and to satisfy the requirements of Ru |
|
| February 13, 2024 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), certify that: I have reviewed this Annual Report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 13, 2024 |
FIRST ADDENDUM TO CONSULTANCY AGREEMENT Exhibit 4.7 FIRST ADDENDUM TO CONSULTANCY AGREEMENT This First Addendum (the "Addendum") is made and entered effective as of the 1st day of January 2023 (the "Effective Date"), by and between: InMode Ltd., Israeli registration number 514073618, of Tavor Building, Sha'ar Yokne'am Industrial Zone, P.O. Box 533, Yoknea'm 20692, Israel (the "Company"); and M.N. Business Strategy Ltd., Israeli incorpor |
|
| February 13, 2024 |
Exhibit 12.1 Certification of the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this Annual Report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fa |
|
| February 13, 2024 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel February 13, 2024 Dear Shareholder, You are cordially invited to attend an annual general meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Monday, April 1, 2024, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industria |
|
| February 13, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 13, 2024 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section §1350, as adopted pursuant to Section § 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Re |
|
| February 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES |
|
| February 13, 2024 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 13, 2024 |
INMD / InMode Ltd. / BoomerangFX International SRL - AMENDMENT NO. 3 Passive Investment SC 13G/A 1 o213240sc13ga3.htm AMENDMENT NO. 3 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 3) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the app |
|
| February 13, 2024 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| February 13, 2024 |
Exhibit 4.13 Fourth Addendum to Unprotected Lease Agreement dated February 28, 2018 Held and signed in on 9 of month3 2023 Between: Shaar Yokneam - Limited Partnership Partnership No.: 550014666 "Ofer Shear Yokneam", 28 Hakidama St., Yokneam (hereinafter: "Lessor") Of the first part; And: Inmode Ltd. PC: 514073618 By authorized signatory, Mr. Moshe Mizrahi, ID: 051825396, who is authorized to sign |
|
| February 13, 2024 |
FIRST ADDENDUM TO EMPLOYMENT AGREEMENT Exhibit 4.8 FIRST ADDENDUM TO EMPLOYMENT AGREEMENT This First Addendum (the "Addendum") is made and entered effective as of the 1st day of January 2023 (the "Effective Date"), by and between: Invasix Corp., a company incorporated under the laws of Canada, whose head office address is: 100 Leek Crescent, Unit 115, Richmond Hill Ontario, Toronto, Canada (the "Company"); and Dr. Michael Kreindel, Can |
|
| November 2, 2023 |
Exhibit 99.1 InMode Reports Third Quarter 2023 Financial Results; Quarterly Revenue of $123.1M Represents 2% Year-Over-Year Growth YOKNEAM, Israel, Nov. 2, 2023- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Highlights: ● Quart |
|
| November 2, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| July 27, 2023 |
Exhibit 99.1 InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth YOKNEAM, Israel, July 27, 2023- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights: |
|
| July 27, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark wh |
|
| May 2, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark whe |
|
| May 2, 2023 |
Exhibit 99.1 InMode Reports First Quarter 2023 Financial Results; Quarterly Revenue of $106.1M Represents 23.5% Year-Over-Year Growth YOKNEAM, Israel, May 2, 2023- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights: ● Quarter |
|
| April 4, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX |
|
| February 14, 2023 |
Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873, 333-236477, 333-252935 and 333-262617) of InMode Ltd. of our report dated February 14, 2023 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in thi |
|
| February 14, 2023 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact nece |
|
| February 14, 2023 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Repor |
|
| February 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 14, 2023 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fa |
|
| February 14, 2023 |
As filed with the Securities and Exchange Commission on February 14, 2023 As filed with the Securities and Exchange Commission on February 14, 2023 Registration No. |
|
| February 14, 2023 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| February 14, 2023 |
Exhibit 99.1 InMode Reports Fourth Quarter and Full Year 2022 Financial Results; Record Quarterly Revenue of $133.6M Represents 21% Year-Over-Year Growth YOKNEAM, Israel, Feb. 14, 2023- InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2022. |
|
| February 14, 2023 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel February 14, 2023 Dear Shareholder, You are cordially invited to attend an annual general meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Monday, April 3, 2023, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industria |
|
| February 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2023 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 14, 2023 |
EX-FILING FEES 4 exhibit107-1.htm FILING FEES TABLE Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) InMode Ltd. (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities CALCULATION OF REGISTRATION FEE Security Type Title of securities to be registered Fee Calculation Rule Amount to be registered(2) Maximum offering price per share Maximum aggregate off |
|
| October 27, 2022 |
Exhibit 99.1 InMode Reports Third Quarter 2022 Financial Results; Record Quarterly Revenue of $121.2 M, Represents 29% Year-Over-Year Growth YOKNEAM, Israel, Oct. 27, 2022-InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlight |
|
| October 27, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| July 28, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark wh |
|
| July 28, 2022 |
Exhibit 99.1 InMode Reports Second Quarter 2022 Financial Results; Record Quarterly Revenue of $113.5M, Represents 30% Year-Over-Year Growth YOKNEAM, Israel, July 28, 2022-InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights: |
|
| May 2, 2022 |
Exhibit 99.1 InMode Reports First Quarter 2022 Financial Results: Quarterly Revenue of $85.9M, GAAP Net Income of $31M Represent 31% and 16% Year-Over-Year Growth, Respectively YOKNEAM, Israel, May 2, 2022-InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2022 |
|
| May 2, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark whe |
|
| April 6, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| March 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number 001-39016 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Princi |
|
| February 14, 2022 |
INMD / Inmode Ltd / BoomerangFX International SRL - AMENDMENT NO. 1 Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 10, 2022 |
Exhibit 4.13 Addendum No. 3 to an Unprotected Lease Dated February 2018 Made and entered into in Yokneam on , 2021 By: Yokneam Gate, Limited Registered Partnership Partnership No. 550014666 Whose address for the purposes of this addendum is in the "Yokneam Gate" complex, 28 HaKidma St. Yokneam - Illit And which will be referred to below, for brevity, as the "Landlord" Of the first part; And betwee |
|
| February 10, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 10, 2022 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Repor |
|
| February 10, 2022 |
EX-15.1 11 exhibit15-1.htm EXHIBIT 15.1 Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873, 333-236477 and 333-252935) of InMode Ltd. of our report dated February 10, 2022 relating to the financial statements and the effectiveness of internal control over financial rep |
|
| February 10, 2022 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| February 10, 2022 |
Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) InMode Ltd. (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities CALCULATION OF REGISTRATION FEE Security Type Title of securities to be registered Fee Calculation Rule Amount to be registered(2) Maximum offering price per share Maximum aggregate offering price Fee Rate Amount of registration fee Equi |
|
| February 10, 2022 |
As filed with the Securities and Exchange Commission on February 10, 2022 As filed with the Securities and Exchange Commission on February 10, 2022 Registration No. |
|
| February 10, 2022 |
Exhibit 4.5 INMODE LTD. 2018 INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD GRANT NOTICE AND RESTRICTED SHARE UNIT AWARD AGREEMENT FOR ALL PARTICIPANTS (OTHER THAN PARTICIPANTS IN ISRAEL) InMode Ltd., a company organized under the laws of the State of Israel (the ?Company?), pursuant to its 2018 Incentive Plan and including the US Sub-Plan appendix thereto setting forth the additional terms applicable |
|
| February 10, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2022 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 10, 2022 |
Exhibit 99.1 InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results: Quarterly Revenue of $110.5M, 47% Year-Over-Year Growth GAAP Net Income of $52.7M, 46% Increase Compared to Q4 2020 YOKNEAM, Israel, Feb. 10, 2022, InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the four |
|
| February 10, 2022 |
Exhibit 4.4 INMODE LTD. 2018 INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD GRANT NOTICE AND RESTRICTED SHARE UNIT AWARD AGREEMENT FOR PARTICIPANTS IN ISRAEL InMode Ltd., a company organized under the laws of the State of Israel (the ?Company?), pursuant to its 2018 Incentive Plan in the form attached hereto as Exhibit A (collectively referred to as the ?Plan,? except where the context otherwise requi |
|
| February 10, 2022 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel February 10, 2022 Dear Shareholder, You are cordially invited to attend an annual general meeting (the ?Meeting?) of the shareholders of InMode Ltd. (the ?Company?), to be held on Monday, April 4, 2022, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industria |
|
| February 10, 2022 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact nece |
|
| February 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ?REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934?? OR ?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934?? For the fiscal year ended December 31, 2021 OR ?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX |
|
| February 10, 2022 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fa |
|
| February 10, 2022 |
Exhibit 4.12 TURN - KEY MANUFACTURING AGREEMENT This Turn - Key Manufacturing Agreement (the "Agreement") is effective as of October 2nd, 2019 (the "Effective Date") by and between: INMODE LTD., with a principal place of business at Tavor Building, Shaar Yokneam, POB 330, Yokneam 2069206, Israel. Hereinafter referred to as ?Customer? And B.Y MEDIMOR LTD. with a principal place of business at 1 Tzi |
|
| October 26, 2021 |
Exhibit 99.1 InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020 YOKNEAM, Israel, October 26, 2021, InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter en |
|
| October 26, 2021 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| September 17, 2021 |
InMode Ltd. Announces 2-for-1 Share Split Exhibit 99.1 InMode Ltd. Announces 2-for-1 Share Split YOKNEAM, Israel, September 17, 2021 /PRNewswire/-InMode Ltd. (Nasdaq: INMD) (?InMode? or the ?Company?), a leading global provider of innovative medical technologies, today announced a two-for-one (2:1) share split of the Company?s ordinary shares, with a record date of September 27, 2021 (the ?Record Date?). The share split will take effect o |
|
| September 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2021 Commission File Number 001-39016 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Pr |
|
| July 28, 2021 |
Exhibit 99.1 InMode Reports Record Second Quarter 2021 Financial Results: Quarterly Revenues of $87.3 Million Represent 184% Year Over Year Growth YOKNEAM, Israel, July 28, 2021, InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Highl |
|
| July 28, 2021 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark wh |
|
| May 5, 2021 |
Exhibit 99.1 InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth GAAP Earnings per Share of $0.63, 320% Year over Year Growth YOKNEAM, Israel, May 05, 2021 /PRNewswire/-InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced consolidated financial results for its fi |
|
| May 5, 2021 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark whe |
|
| April 26, 2021 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark w |
|
| April 26, 2021 |
AGREEMENT Dated April 23, 2021 ("Effective Date") Exhibit 10.1 AGREEMENT Dated April 23, 2021 ("Effective Date") Made by and between: Party A: Dilazar Limited, a company incorporated under the laws of Jersey, registered nu# 66820, of 1st Floor 2 Mulcaster Street St Helier Jersey JE2 3NJ, Channel Islands (?Dilazar?); Party B: Wigmore Medical Limited, a company incorporated under the laws of the United Kingdom, registered nu# 03310740, of 23 Wigmor |
|
| April 8, 2021 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 1)* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) InMode Ltd. (Name of Issuer) Ordinary shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) December |
|
| February 12, 2021 |
EX-99.1 2 tm215949d2ex1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT February 12, 2021 Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees that ISRAEL HEALTHCARE VENTURES 2 L.P. (“IHCV 2”) may file as necessary on behalf of the undersigned with the Securities and Exchange Commission a Schedule 13G or Schedule |
|
| February 10, 2021 |
Consent of Kesselman & Kesselman, a member firm of PricewaterhouseCoopers Inter-national Limited, an Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-233873 and 333-236477) of InMode Ltd. of our report dated February 10, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F. Tel-Aviv, I |
|
| February 10, 2021 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact nece |
|
| February 10, 2021 |
Exhibit 12.1 Certification by the Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), certify that: 1. I have reviewed this annual report on Form 20-F of the Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fa |
|
| February 10, 2021 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 10, 2021 |
Exhibit 4.10 [translator’s note: each page is signed by both parties] ADDENDUM NUMBER 2 TO UNPROTECTED TENANCY AGREEMENT EXECUTED IN FEBRUARY 2018 Made and executed in Yokneam on January , 2020 Between: Shaar Yokneam, Registered Limited Partnership Partnership number 550014666 by its authorized signatories Itai Kaplan, ID 058768615 and Yael Gross, ID 55984280 of which address for the purpose of th |
|
| February 10, 2021 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel February 10, 2021 Dear Shareholder, You are cordially invited to attend an annual general meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Monday, April 5, 2021, beginning at 17:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industria |
|
| February 10, 2021 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| February 10, 2021 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Repor |
|
| February 10, 2021 |
As filed with the Securities and Exchange Commission on February 10, 2021 Registration No. |
|
| February 10, 2021 |
Exhibit 4.12 COMPENSATION POLICY INMODE LTD. Compensation Policy for Executive Officers and Directors Last Updated: April 2, 2020 Table of Contents Page A. Overview and Objectives 3 B. Base Salary and Benefits 5 C. Cash Bonuses 7 D. Equity-Based Compensation 8 E. Retirement and Termination of Service Arrangements (Excluding Directors) 10 F. Exemption, Indemnification and Insurance 11 G. Arrangemen |
|
| February 10, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2021 Commission File Number 001-39016 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Pri |
|
| February 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX |
|
| February 10, 2021 |
Exhibit 99.1 InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth YOKNEAM, Israel, February 10, 2021 /PRNewswire/-InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced consolidated financial results for its fourth quarter and full year ended D |
|
| January 12, 2021 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| November 12, 2020 |
Exhibit 99.1 InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63 YOKNEAM, Israel, November 12, 2020/ PRNewswire/ InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced consolidated financial r |
|
| November 12, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| November 12, 2020 |
Share Exchange Agreement dated November 11, 2020, by and among the Company, GIBF and the Chinese JV Exhibit 10.1 EXCUTION COPY 定稿 AGREEMENT 协议 Dated November 11, 2020 ("Effective Date") 日期：2020年 11 月11 日（下称“生效日期”） Made by and between: 契约方： Party A: Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP), acting by its general partner Guangzhou Elim Biotech Industrial Venture Capital Management Company (“GIBF”), 甲方： 广州中以生物产业投资基金合伙企业（有限合伙），执行事务合伙人为广州以琳生物产业创业投资管理有限公司（“中以基金” 或“甲方”）， whose legal add |
|
| September 2, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check ma |
|
| August 5, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| August 5, 2020 |
Exhibit 99.1 InMode Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $30.8 Million, GAAP and *Non-GAAP Diluted Earnings per Share of $0.21 and $0.24 YOKNEAM, Israel, August 05, 2020/ PRNewswire/ InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced consolidated financial results for its second quarter ended June 30, |
|
| June 19, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha’ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| May 22, 2020 |
EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary shares, par value NIS 0. |
|
| May 22, 2020 |
SC 13G 1 tm2020735d1sc13g.htm SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) N/A (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| May 11, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark whe |
|
| May 11, 2020 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel May 11, 2020 Dear Shareholder, You are cordially invited to attend a Special General Meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Tuesday, June 16, 2020, beginning at 18:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industrial Pa |
|
| May 6, 2020 |
Current Report of Foreign Issuer - 6-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark whe |
|
| May 6, 2020 |
Exhibit 99.1 InMode Reports First Quarter 2020 Financial Results; Quarterly Revenues of $40.4 Million Represent 32% Year over Year Growth YOKNEAM, Israel, May 06, 2020/ PRNewswire/ InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced financial results for its first quarter ended March 31, 2020. First Quarter 2020 Highlights: • Quarter |
|
| April 6, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13In a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| March 23, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark w |
|
| March 23, 2020 |
InMode Provides COVID-19 Business Update Exhibit 99.1 InMode Provides COVID-19 Business Update Yokneam, Israel, March 23, 2020 InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today provided an update regarding its business activities in light of the ongoing global health situation caused by the COVID-19. As of today, InMode?s Q1 2020 revenue from devices and consumables is in line with |
|
| February 18, 2020 |
Exhibit 12.1 Certification of Principal Executive Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Moshe Mizrahy, Chief Executive Officer, certify that: 1. I have reviewed this annual report on Form 20-F of InMode Ltd., referred to as the registrant; 2. Based on my knowledge, this report does not contain any untrue st |
|
| February 18, 2020 |
Exhibit 13.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Yair Malca, Chief Financial Officer of InMode Ltd. (the “Company”), hereby certify, to my knowledge, that: 1. The Annual Report o |
|
| February 18, 2020 |
Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-233873) of InMode Ltd. of our report dated February 18, 2020 relating to the financial statements, which appears in this Form 20-F. Tel-Aviv, Israel /s/ Kesselman & Kesselman February 18, 2020 Certified Public Accountants (lsr. |
|
| February 18, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 18, 2020 |
Exhibit 13.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Moshe Mizrahy, Chief Executive Officer of InMode Ltd. (the ?Company?), hereby certify, to my knowledge, that: 1. The Annual Repor |
|
| February 18, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2020 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| February 18, 2020 |
Exhibit 99.1 InMode Reports Record Fourth Quarter and Full Year 2019 Financial Results Quarterly Revenues of $47 Million Represent 63% Year over Year Growth YOKNEAM, Israel, February 18, 2020/ PRNewswire/- InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced financial results for the fourth quarter and full year ended December 31, 201 |
|
| February 18, 2020 |
Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel Exhibit 99.1 Tavor Building, Sha'ar Yokneam, P.O. Box 533, Yokneam 2069206, Israel February 18, 2020 Dear Shareholder, You are cordially invited to attend an annual general meeting (the “Meeting”) of the shareholders of InMode Ltd. (the “Company”), to be held on Thursday, April 2, 2020, beginning at 18:00, Israel time, at the offices of the Company located at Tavor Building, Sha'ar Yokneam Industr |
|
| February 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXC |
|
| February 18, 2020 |
As filed with the Securities and Exchange Commission on February 18, 2020 Registration No. |
|
| February 18, 2020 |
Exhibit 12.2 Certification of Principal Financial Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 I, Yair Malca, Chief Financial Officer, certify that: 1. I have reviewed this annual report on Form 20-F of InMode Ltd., referred to as the registrant; 2. Based on my knowledge, this report does not contain any untrue state |
|
| February 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) InMode Ltd. (Name of Issuer) Ordinary shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) December 31 |
|
| February 14, 2020 |
EX-99.1 2 tm207623d1ex-1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT February 14, 2020 Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees that ISRAEL HEALTHCARE VENTURES 2 L.P. (“IHCV 2”) may file as necessary on behalf of the undersigned with the Securities and Exchange Commission a Schedule 13G or Schedule |
|
| February 14, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) N/A (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| February 14, 2020 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * InMode Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M5425M 103 (CUSIP Number) N/A (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched |
|
| November 5, 2019 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2019 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mar |
|
| November 5, 2019 |
Exhibit 99.1 InMode Reports Third Quarter 2019 Record Revenue of $40 Million; Reflects Growth of 57% Year-Over-Year; Net Income Increased 87% to $16.2 Million YOKNEAM, Israel, November 5, 2019 /PRNewswire/- InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading global provider of innovative medical technologies, today announced financial results for the third quarter ended September 30, 2019. Third Quar |
|
| September 20, 2019 |
As filed with the Securities and Exchange Commission on September 20, 2019 As filed with the Securities and Exchange Commission on September 20, 2019 Registration No. |
|
| August 13, 2019 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2019 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| August 13, 2019 |
Exhibit 99.1 InMode Reports Second Quarter 2019 Financial Results; Record Quarterly Revenue of $38.8 million Reflects Growth of 55% Over Prior Year Net Income Increased 109% Over Prior Year to $15.8 million InMode Completed a Successful Initial Public Offering with Gross Proceeds of $70 million LAKE FOREST, Calif., August 13, 2019 /PRNewswire/- InMode Ltd. (Nasdaq: INMD) (?InMode?), a leading glob |
|
| August 12, 2019 |
InMode Ltd. Announces Closing of Initial Public Offering Exhibit 99.1 FINAL InMode Ltd. Announces Closing of Initial Public Offering LAKE FOREST, Calif., August 12, 2019 /PRNewswire/- InMode Ltd. (Nasdaq:INMD) (?InMode?) announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissi |
|
| August 12, 2019 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2019 INMODE LTD. (Exact name of registrant as specified in its charter) Tavor Building, Sha?ar Yokneam P.O. Box 533 Yokneam 2069206 Israel (Address of Principal Executive Offices) Indicate by check mark |
|
| August 12, 2019 |
Exhibit 3.1 InMode Ltd. Amended and Restated Articles of Association of a Public Company Effective as of August 7, 2019 Public Company Limited by Shares The Companies Law, 5759 - 1999 Amended and Restated Articles of Association of InMode Ltd. (?????? ??"?) Preliminary 1. Definitions; Interpretation 1.1 In these Articles, the following terms (whether or not capitalized) shall bear the meanings set |
|
| August 12, 2019 |
INMODE LTD. 5,000,000 Ordinary Shares UNDERWRITING AGREEMENT Exhibit 1.1 Execution Version INMODE LTD. 5,000,000 Ordinary Shares UNDERWRITING AGREEMENT August 7, 2019 Barclays Capital Inc. UBS Securities LLC, As Representatives of the several Underwriters named in Schedule I attached hereto c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 Ladies and Gentlemen: I |
|
| August 8, 2019 |
5,000,000 Shares InMode Ltd. Ordinary Shares TABLE OF CONTENTS ?Filed Pursuant to Rule 424(b)(4)? ?Registration No. 333-232615? PROSPECTUS ? 5,000,000 Shares InMode Ltd. Ordinary Shares ? This is our initial public offering of our ordinary shares. We are offering 5,000,000 of our ordinary shares. No public market currently exists for our ordinary shares. The initial public offering price is $14.00 per ordinary share. We have been approved to |
|
| August 5, 2019 |
[Remainder of Page Intentionally Left Blank] August 5, 2019 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Heather Percival Mr. Russell Mancuso Re: InMode Ltd. (the ?Company?) Registration Statement on Form F-1 (File No. 333-232615) Acceleration Request Requested Date: Wednesday, August 7, 2019 Requested Time: 4:00 p.m. Eastern Daylight Time Ladies and Gentlemen: As |
|
| August 5, 2019 |
InMode Ltd. Tavor Building, Sha’ar Yokneam, P.O. Box 533 Yokneam 2069206, Israel InMode Ltd. Tavor Building, Sha?ar Yokneam, P.O. Box 533 Yokneam 2069206, Israel August 5, 2019 VIA EDGAR AND OVERNIGHT DELIVERY Heather Percival Russell Mancuso United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: InMode Ltd. Registration Statement on Form F-1 (File No. 333-232615) Registration Statement on Form 8-A Ladies |
|
| August 5, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 InMode Ltd. (Exact name of registrant as specified in its charter) State of Israel Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) |
|
| August 2, 2019 |
Mayer Brown LLP 1221 Avenue of the Americas New York, New York 10020-1001 Main Tel +1 212 506 2500 Main Fax +1 212 262 1910 www. |
|
| August 2, 2019 |
As filed with the Securities and Exchange Commission on August 2, 2019 ? As filed with the Securities and Exchange Commission on August 2, 2019 Registration No. |
|
| July 29, 2019 |
Articles of Association, as amended, as currently in effect Exhibit 3.1 INVASIX LTD. ARTICLES OF ASSOCIATION Duly adopted on March 6, 2008 TABLE OF CONTENTS PAGE INTERPRETATION 1 PURPOSE AND LIMITATIONS 2 CAPITAL, SHARES AND RIGHTS 3 CALL ON SHARES 3 FORFEITURE AND LIEN 4 TRANSFER OF SHARES 5 BRING ALONG 5 RIGHT OF FIRST REFUSAL 6 TRANSMISSION OF SHARES 8 ALTERATIONS OF THE AUTHORIZED CAPITAL 8 MODIFICATION OF CLASS RIGHTS 9 GENERAL MEETINGS 9 PROCEEDINGS |
|
| July 29, 2019 |
As filed with the Securities and Exchange Commission on July 29, 2019 F-1/A 1 tv525103-f1a.htm F-1/A TABLE OF CONTENTS As filed with the Securities and Exchange Commission on July 29, 2019 Registration No. 333-232615 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INMODE LTD. (Exact name of registrant as specified in its charter) Not Applicable (Translation of |
|
| July 29, 2019 |
Exhibit 10.9 TURN - KEY MANUFACTURING AGREEMENT This Turn - Key Manufacturing Agreement (the ?Agreement?) is effective as of the 1.4.2011 (the ?Effective Date?) by and between: INVASIX LTD., with a principal place of business at Tavor Building, Shaar Yokneam, POB 533, Yokneam 20692, Israel. Hereinafter referred to as ?Customer? And FLEXTRONICS ISRAEL LTD. with a principal place of business at Indu |
|
| July 29, 2019 |
Exhibit 10.10 TUNRKEY MANUFACTURING AGREEMENT This agreement is effective as of the November 7, 2013 (the Effective Date) by and between: INVASIX Ltd., with a principal place of business at Tavor building, POB 533, Yokneam, Israel, Hereinafter referred to as ?Customer? And STI Laser Industries Ltd., with a principal place of business at Industrial Zone Or Aqiva 3065001 P.O.B. 34, Israel Hereinafte |
|
| July 29, 2019 |
InMode Ltd. 2018 Incentive Plan Exhibit 10.3 INMODE LTD. 2018 INCENTIVE PLAN 1. Purpose of The Plan: 1.1 This plan, as amended from time to time, shall be known as the "InMode Ltd. 2018 Incentive Plan". 1.2 The Plan is intended to provide an incentive to employees, directors, consultants and/or contractors of the Group worldwide, by providing them with opportunities to be granted Awards in the Company, pursuant to the Plan. 1.3 |
|
| July 29, 2019 |
Form of Articles of Association to be effective upon the effectiveness of the registration statement Exhibit 3.2 InMode Ltd. Amended and Restated Articles of Association of a Public Company Effective as of [, 2019] Public Company Limited by Shares The Companies Law, 5759 - 1999 Amended and Restated Articles of Association of InMode Ltd. (?????? ??"?) Preliminary 1. Definitions; Interpretation 1.1 In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth |
|
| July 26, 2019 |
Mayer Brown LLP 1221 Avenue of the Americas New York, New York 10020-1001 Main Tel +1 212 506 2500 Main Fax +1 212 262 1910 www. |
|
| July 11, 2019 |
TABLE OF CONTENTS As filed with the Securities and Exchange Commission on July 11, 2019. |
|
| July 11, 2019 |
Articles of Association, as amended, as currently in effect Exhibit 3.1 INVASIX LTD. ARTICLES OF ASSOCIATION Duly adopted on March 6, 2008 TABLE OF CONTENTS PAGE INTERPRETATION 1 PURPOSE AND LIMITATIONS 2 CAPITAL, SHARES AND RIGHTS 3 CALL ON SHARES 3 FORFEITURE AND LIEN 4 TRANSFER OF SHARES 5 BRING ALONG 5 RIGHT OF FIRST REFUSAL 6 TRANSMISSION OF SHARES 8 ALTERATIONS OF THE AUTHORIZED CAPITAL 8 MODIFICATION OF CLASS RIGHTS 9 GENERAL MEETINGS 9 PROCEEDINGS |
|
| July 11, 2019 |
EX-10.9 14 tv524581ex10-9.htm EXHIBIT 10.9 Exhibit 10.9 TURN - KEY MANUFACTURING AGREEMENT This Turn - Key Manufacturing Agreement (the “Agreement”) is effective as of the 1.4.2011 (the “Effective Date”) by and between: INVASIX LTD., with a principal place of business at Tavor Building, Shaar Yokneam, POB 533, Yokneam 20692, Israel. Hereinafter referred to as “Customer” And FLEXTRONICS ISRAEL LTD. |
|
| July 11, 2019 |
Exhibit 10.11 OFFICES LEASE AGREEMENT November 2015 Version InMode Ltd Sha?ar Yokneam 514073618 Limited Partnership [Signature] [Signature] TABLE OF CONTENTS Chapter Description Page 1. The Preamble And Appendices 4 2. Definitions 5 3. The Lease Transaction 9 4. The Parties Declarations 9 5. The Area Of The Premises 10 6. The Purpose Of The Lease 11 7. The Lease Period 13 8. Rent 16 9. Value Added |
|
| July 11, 2019 |
Exhibit 4.1 SPECIMEN SHARE CERTIFICATE InMode Ltd. Number Shares INMD CUSIP: See Reverse for Certain Definitions INMODE LTD. INCORPORATED UNDER THE LAWS OF THE STATE OF ISRAEL THIS CERTIFIES that is the Registered Holder of FULLY PAID AND NON-ASSESSABLE ORDINARY SHARES OF NIS 0.01 PAR VALUE EACH of InMode Ltd. transferable on the books of the Company by the holder hereof in person or by duly autho |
|
| July 11, 2019 |
Exhibit 10.8 Investment by Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP) In Invasix Ltd. Closing Date: Jan. 11, 2017 Table of Contents # Exhibit No. Title 1 - Equity Joint Venture Agreement 2 19.1.3 Business License 3 19.1.7 Amended and Restated Articles of Association of the Company 4 19.1.9 Indemnification Agreement 5 19.1.11 License Agreement 6 19.1.12 Resolution of the Company Appro |
|
| July 11, 2019 |
Consultancy Agreement, dated August 1, 2018, by and between InMode Ltd. and Mr. Moshe Mizrahy EX-10.5 10 tv524581ex10-5.htm EXHIBIT 10.5 Exhibit 10.5 CONSULTANCY AGREEMENT This Consultancy Agreement (“Agreement”), is made effective as of August 1, 2018 (“Effective Date”) by and between: InMode Ltd., duly incorporated under the laws of the State of Israel, located at Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 20692, Israel (the “Company”); and M.N. Business Strategy Ltd. Israeli |
|
| July 11, 2019 |
Form of Indemnification Agreement EX-10.4 9 tv524581ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 INMODE LTD. INDEMNIFICATION AND EXCULPATION AGREEMENT , 2019 To: Holder of Israeli ID Number / [] Passport Number: (the “Indemnitee”) This Indemnification and Exculpation Agreement (“Indemnification Agreement”) is being entered into effective as of , 2019, pursuant to the resolutions of the Board of Directors of InMode Ltd., (Israeli Company N |
|
| July 11, 2019 |
Exhibit 21.1 InMode Ltd. List of Subsidiaries Subsidiary Jurisdiction of Incorporation Invasix Inc. Delaware, USA Invasix Corp. Canada InMode M.D. Ltd. Israel Invasix UK Ltd. United Kingdom InMode Japan KK Japan Invasix Iberia S.L. Spain Guangzhou InMode Medical Technology Ltd. China InMode Asia Limited. Hong Kong InMode India Private Limited India |
|
| July 11, 2019 |
Form of Underwriting Agreement Exhibit 1.1 INMODE LTD. Ordinary Shares UNDERWRITING AGREEMENT , 2019 Barclays Capital Inc. UBS Securities LLC, As Representatives of the several Underwriters named in Schedule I attached hereto c/o Barclays Capital Inc. 745 Seventh Avenue New York, New York 10019 c/o UBS Securities LLC 1285 Avenue of the Americas New York, New York 10019 Ladies and Gentlemen: InMode Ltd., a company organized unde |
|
| July 11, 2019 |
EX-10.7 12 tv524581ex10-7.htm EXHIBIT 10.7 Exhibit 10.7 AWARD AGREEMENT This Award Agreement (this “Award Agreement”) is entered into as of the date hereof, by between InMode Ltd., a private company No. 514073618 of Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 20692, Israel (the “Company”) and [], [] Passport / Israeli ID Number [], of [] (the “Participant”) (the Company and the Participa |
|
| July 11, 2019 |
Invasix Ltd. 2008 Israeli Option Plan (English translation) EX-10.2 7 tv524581ex10-2.htm EXHIBIT 10.2 Exhibit 10.2 INVASIX LTD. THE 2008 ISRAEL OPTION PLAN -i- Invasix Ltd. 2008 Israel Option Plan 1. NAME OF THE PLAN This plan, and the amendments to be made thereto from time to time, shall be named the 2008 Israel Option Plan of Invasix Ltd. (hereinafter: the “Plan”). 2. SCOPE AND PURPOSEOF THE PLAN The Plan is intended to provide an incentive to attract n |
|
| July 11, 2019 |
Exhibit 10.12 Wigmore Medical Limited (?Wigmore?) - Invasix Ltd (?Invasix?) Founders Memorandum of Understanding 1. The Company Wigmore, on behalf of the Parties, incorporated ?Invasix UK Ltd?, a limited liability company in the United Kingdom (the ?Company?), for the purpose of marketing Invasix Products to plastic surgeons, dermatologists, general practices, spa facilities, specialized hair remo |
|
| July 11, 2019 |
Exhibit 10.13 COMPENSATION POLICY INMODE LTD. Compensation Policy for Executive Officers and Directors ADOPTED: , 2019 1 Table of Contents Page A. Overview and Objectives 3 B. Base Salary and Benefits 5 C. Cash Bonuses 7 D. Equity-Based Compensation 8 E. Retirement and Termination of Service Arrangements (Excluding Directors) 10 F. Exemption, Indemnification and Insurance 11 G. Arrangements upon C |
|
| July 11, 2019 |
Form of Articles of Association to be effective upon the effectiveness of the registration statement Exhibit 3.2 InMode Ltd. Amended and Restated Articles of Association of a Public Company Effective as of [, 2019] Public Company Limited by Shares The Companies Law, 5759 - 1999 Amended and Restated Articles of Association of InMode Ltd. (?????? ??"?) Preliminary 1. Definitions; Interpretation 1.1 In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth |
|
| July 11, 2019 |
Employment Agreement, dated July 1, 2017, by and between Invasix Corp. and Dr. Michael Kreindel EX-10.6 11 tv524581ex10-6.htm EXHIBIT 10.6 Exhibit 10.6 Employment Agreement This Employment Agreement (the “Agreement”) is entered into by and between: Invasix Corp., a company incorporated under the laws of Canada, whose head office address is: 30 East Beaver Creek Road, Unit 115, Richmond Hill Ontario, Toronto Canada (the “Company”); And Dr. Michael Kreindel, Canadian Passport Number 918328121, |
|
| July 11, 2019 |
Exhibit 10.3 INMODE LTD. 2018 INCENTIVE PLAN 1. Purpose of The Plan: 1.1 This plan, as amended from time to time, shall be known as the "InMode Ltd. 2018 Incentive Plan". 1.2 The Plan is intended to provide an incentive to employees, directors, consultants and/or contractors of the Group worldwide, by providing them with opportunities to be granted Awards in the Company, pursuant to the Plan. 1.3 |
|
| July 11, 2019 |
EX-10.10 15 tv524581ex10-10.htm EXHIBIT 10.10 Exhibit 10.10 TUNRKEY MANUFACTURING AGREEMENT This agreement is effective as of the November 7, 2013 (the Effective Date) by and between: INVASIX Ltd., with a principal place of business at Tavor building, POB 533, Yokneam, Israel, Hereinafter referred to as “Customer” And STI Laser Industries Ltd., with a principal place of business at Industrial Zone |
|
| July 11, 2019 |
Invasix Ltd. 2008 ROW Option Plan Exhibit 10.1 INVASIX LTD. 2008 ROW OPTION PLAN TABLE OF CONTENTS 1. Purpose 2 2. Definitions 2 3. Stock Subject to the Plan 5 4. Administration of the Plan 5 5. Eligibility 6 6. Terms and Conditions of Awards 7 7. Award Exercise or Purchase Price 8 8. Exercise of Award 9 9. Conditions Upon Issuance of Shares 10 10. Adjustments Upon Changes in Capitalization 10 11. Corporate Transactions 11 12. Eff |
|
| July 11, 2019 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| July 1, 2019 |
As submitted confidentially with the Securities and Exchange Commission on June 28, 2019. DRS/A 1 filename1.htm TABLE OF CONTENTS As submitted confidentially with the Securities and Exchange Commission on June 28, 2019. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INMODE LTD. (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registran |
|
| April 5, 2019 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 mayerbrown. |
|
| April 5, 2019 |
effortsinexistingandnewmarkets.Wealsointendtocontinuetomakeinvestmentsinresearchand developmenteffortstodevelopournextgenerationproducts.Asaresultof theseandotherfactors,we expectouroperatingexpensestoincreaseinthefuture. Componentsof OurResultsof Operations Revenues Wegenerateourrevenuesprimarilyfromthesaleof energy-basedmedicalaestheticproducts,which consistof platformsandnon-consumablehandpiece |
|
| March 13, 2019 |
As submitted confidentially with the Securities and Exchange Commission on March 13, 2019. TABLE OF CONTENTS As submitted confidentially with the Securities and Exchange Commission on March 13, 2019. |
|
| December 13, 2018 |
Weforecastsalestodeterminerequirementsforourproductsandif ourforecastsareincorrect,wemay experienceeithershipmentdelaysorincreasedcosts. |
|
| December 13, 2018 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 www. |
|
| November 8, 2018 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 www. |
|
| November 8, 2018 |
As submitted confidentially to the Securities and Exchange Commission on November 8, 2018. DRS/A 1 filename1.htm TABLE OF CONTENTS As submitted confidentially to the Securities and Exchange Commission on November 8, 2018. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 3 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INMODE LTD. (Exact name of registrant as specified in its charter) Not Applicable (Tran |
|
| November 8, 2018 |
Wigmore Medical Limited (“Wigmore”) - Invasix Ltd (“Invasix”) Founders Memorandum of Understanding EX-10.12 2 filename2.htm Exhibit 10.12 Wigmore Medical Limited (“Wigmore”) - Invasix Ltd (“Invasix”) Founders Memorandum of Understanding 1. The Company Wigmore, on behalf of the Parties, incorporated “Invasix UK Ltd”, a limited liability company in the United Kingdom (the “Company”), for the purpose of marketing Invasix Products to plastic surgeons, dermatologists, general practices, spa faciliti |
|
| November 2, 2018 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 www. |
|
| October 11, 2018 |
Exhibit 10.13 [InMode letterhead] August 30th, 2018 Mr. Bedo Eghiayan Chief Executive Officer Wigmore Medical Limited 23 Wigmore Street London W1U 1PL United Kingdom Re: Consent to Waive Equity Swap Provision of MOU Dear Mr. Eghiayan, Reference is made to the Founders Memorandum of Understanding, dated as of March 4, 2014 (the ?MOU?), by and between InMode Ltd. (formerly Invasix Ltd.) (?Inmode?) a |
|
| October 11, 2018 |
Exhibit 10.14 [InMode letterhead] September 12th, 2018 Mr. Shuki Gleitman Chairman GIBF ? Guangzhou Sino-Israel Bio-Industry Investment Fund LLP Atidim Industrial Park, Israel Re: Consent to Waive Equity Swap Provision of Agreement Dear Mr. Gleitman, Reference is made to the agreement dated as of September 9th, 2016 (the ?Agreement), by and between InMode Ltd. (formerly Invasix Ltd.) (?Inmode?) an |
|
| October 11, 2018 |
EX-10.8 2 filename2.htm Exhibit 10.8 Investment by Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP) In Invasix Ltd. Closing Date: Jan. 11, 2017 Table of Contents # Exhibit No. Title 1 - Equity Joint Venture Agreement 2 19.1.3 Business License 3 19.1.7 Amended and Restated Articles of Association of the Company 4 19.1.9 Indemnification Agreement 5 19.1.11 License Agreement 6 19.1.12 Resolut |
|
| October 11, 2018 |
Wigmore Medical Limited (“Wigmore”) - Invasix Ltd (“Invasix”) Founders Memorandum of Understanding Exhibit 10.12 Wigmore Medical Limited (?Wigmore?) - Invasix Ltd (?Invasix?) Founders Memorandum of Understanding 1. The Company Wigmore, on behalf of the Parties, incorporated ?Invasix UK Ltd?, a limited liability company in the United Kingdom (the ?Company?), for the purpose of marketing Invasix Products to plastic surgeons, dermatologists, general practices, spa facilities, specialized hair remo |
|
| October 11, 2018 |
Mayer Brown LLP 1221 Avenue of the Americas New York, NY 10020-1001 United States of America T: +1 212 506 2500 F: +1 212 262 1910 www. |
|
| October 11, 2018 |
As submitted confidentially to the Securities and Exchange Commission on October 11, 2018. TABLE OF CONTENTS As submitted confidentially to the Securities and Exchange Commission on October 11, 2018. |
|
| September 7, 2018 |
EX-10.8 2 filename2.htm Exhibit 10.8 Investment by Guangzhou Sino-Israel Bio-Industry Investment Fund (LLP) In Invasix Ltd. Closing Date: Jan. 11, 2017 Table of Contents # Exhibit No. Title 1 - Equity Joint Venture Agreement 2 19.1.3 Business License 3 19.1.7 Amended and Restated Articles of Association of the Company 4 19.1.9 Indemnification Agreement 5 19.1.11 License Agreement 6 19.1.12 Resolut |
|
| September 7, 2018 |
Mayer Brown LLP 1221 Avenue of the Americas New York, New York 10020-1001 Main Tel +1 212 506 2500 Main Fax +1 212 262 1910 www. |
|
| September 7, 2018 |
As submitted confidentially to the Securities and Exchange Commission on September 7, 2018. TABLE OF CONTENTS As submitted confidentially to the Securities and Exchange Commission on September 7, 2018. |
|
| July 25, 2018 |
TURN - KEY MANUFACTURING AGREEMENT EX-10.9 7 filename7.htm Exhibit 10.9 TURN - KEY MANUFACTURING AGREEMENT This Turn - Key Manufacturing Agreement (the “Agreement”) is effective as of the 1.4.2011 (the “Effective Date”) by and between: INVASIX LTD., with a principal place of business at Tavor Building, Shaar Yokneam, POB 533, Yokneam 20692, Israel. Hereinafter referred to as “Customer” And FLEXTRONICS ISRAEL LTD. with a principal p |
|
| July 25, 2018 |
INVASIX LTD. ARTICLES OF ASSOCIATION Duly adopted on March 6, 2008 TABLE OF CONTENTS EX-3.1 2 filename2.htm Exhibit 3.1 INVASIX LTD. ARTICLES OF ASSOCIATION Duly adopted on March 6, 2008 TABLE OF CONTENTS PAGE INTERPRETATION 1 PURPOSE AND LIMITATIONS 2 CAPITAL, SHARES AND RIGHTS 3 CALL ON SHARES 3 FORFEITURE AND LIEN 4 TRANSFER OF SHARES 5 BRING ALONG 5 RIGHT OF FIRST REFUSAL 6 TRANSMISSION OF SHARES 8 ALTERATIONS OF THE AUTHORIZED CAPITAL 8 MODIFICATION OF CLASS RIGHTS 9 GENERAL |
|
| July 25, 2018 |
EX-10.5 5 filename5.htm Exhibit 10.5 CONSULTANCY AGREEMENT Invasix Ltd., duly incorporated under the laws of the State of Israel, located at Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam 20692, Israel (the “Company”); and M.N. Business Strategy Ltd. Israeli incorporation number 512297508, of 2 Yatziz St., Tel-Aviv, Israel, via its sole principal Mr. Moshe Mizrahy (respectively the "Consult |
|
| July 25, 2018 |
TUNRKEY MANUFACTURING AGREEMENT Exhibit 10.10 TUNRKEY MANUFACTURING AGREEMENT This agreement is effective as of the November 7, 2013 (the Effective Date) by and between: INVASIX Ltd., with a principal place of business at Tavor building, POB 533, Yokneam, Israel, Hereinafter referred to as ?Customer? And STI Laser Industries Ltd., with a principal place of business at Industrial Zone Or Aqiva 3065001 P.O.B. 34, Israel Hereinafte |
|
| July 25, 2018 |
As submitted confidentially to the Securities and Exchange Commission on July 25, 2018. DRS 1 filename1.htm TABLE OF CONTENTS As submitted confidentially to the Securities and Exchange Commission on July 25, 2018. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 INMODE LTD. (Exact name of registrant as specified in its charter) Not Applicable (Translation of Registrant’s |
|
| July 25, 2018 |
OFFICES LEASE AGREEMENT November 2015 Version Exhibit 10.11 OFFICES LEASE AGREEMENT November 2015 Version InMode Ltd Sha’ar Yokneam 514073618 Limited Partnership [Signature] [Signature] TABLE OF CONTENTS Chapter Description Page 1. The Preamble And Appendices 4 2. Definitions 5 3. The Lease Transaction 9 4. The Parties Declarations 9 5. The Area Of The Premises 10 6. The Purpose Of The Lease 11 7. The Lease Period 13 8. Rent 16 9. Value Added |
|
| July 25, 2018 |
Exhibit 21.1 InMode Ltd. List of Subsidiaries Subsidiary Jurisdiction of Incorporation Invasix Inc. Delaware, USA Invasix Corp. Canada InMode M.D. Ltd. Israel Invasix UK Ltd. United Kingdom InMode Japan KK Japan Invasix Iberia S.L. Spain Guangzhou InMode Medical Technology Ltd. China InMode Asia Limited. Hong Kong |
|
| July 25, 2018 |
INVASIX LTD. 2008 ROW OPTION PLAN TABLE OF CONTENTS Exhibit 10.1 INVASIX LTD. 2008 ROW OPTION PLAN TABLE OF CONTENTS 1. Purpose 2 2. Definitions 2 3. Stock Subject to the Plan 5 4. Administration of the Plan 5 5. Eligibility 6 6. Terms and Conditions of Awards 7 7. Award Exercise or Purchase Price 8 8. Exercise of Award 9 9. Conditions Upon Issuance of Shares 10 10. Adjustments Upon Changes in Capitalization 10 11. Corporate Transactions 11 12. Eff |
|
| July 25, 2018 |
INVASIX LTD. THE 2008 ISRAEL OPTION PLAN EX-10.2 4 filename4.htm Exhibit 10.2 INVASIX LTD. THE 2008 ISRAEL OPTION PLAN -i- Invasix Ltd. 2008 Israel Option Plan 1. NAME OF THE PLAN This plan, and the amendments to be made thereto from time to time, shall be named the 2008 Israel Option Plan of Invasix Ltd. (hereinafter: the “Plan”). 2. SCOPE AND PURPOSEOF THE PLAN The Plan is intended to provide an incentive to attract new employees, dire |
|
| July 25, 2018 |
Exhibit 10.6 Employment Agreement This Employment Agreement (the ?Agreement?) is entered into by and between: Invasix Corp., a company incorporated under the laws of Canada, whose head office address is: 30 East Beaver Creek Road, Unit 115, Richmond Hill Ontario, Toronto Canada (the ?Company?); And Dr. Michael Kreindel, Canadian Passport Number 918328121, of 20 Sorrento Dr., Richmond Hill, Canada |
